Literature DB >> 31964377

Correction to: The use of ultrasensitive quantitative-PCR to assess the impact of primaquine on asymptomatic relapse of Plasmodium vivax infections: a randomized, controlled trial in Lao PDR.

Koukeo Phommasone1,2,3, Frank van Leth2,3, Mallika Imwong4,5, Gisela Henriques4, Tiengkham Pongvongsa6, Bipin Adhikari4,7, Thomas J Peto4,7, Cholrawee Promnarate8, Mehul Dhorda4,7,8, Pasathorn Sirithiranont4, Mavuto Mukaka4,7, Pimnara Peerawaranun4, Nicholas P J Day4,7, Frank Cobelens2,3, Arjen M Dondorp4,7, Paul N Newton1,7, Nicholas J White4,7, Lorenz von Seidlein9,10, Mayfong Mayxay1,11.   

Abstract

Following publication of the original article [1], it was brought to the authors' attention that one of the names in the author list had been provided with the incorrect spelling.

Entities:  

Year:  2020        PMID: 31964377      PMCID: PMC6971976          DOI: 10.1186/s12936-020-3124-0

Source DB:  PubMed          Journal:  Malar J        ISSN: 1475-2875            Impact factor:   2.979


Correction to: Malar J (2020) 19:4 10.1186/s12936-019-3091-5

Following publication of the original article [1], it was brought to the authors’ attention that one of the names in the author list had been provided with the incorrect spelling. Namely, ‘Mehul Dhorda’ had been incorrectly spelled as ‘Mehul Dorda’. The error has since been corrected in the original article. The authors apologize for any inconvenience caused.
  1 in total

1.  The use of ultrasensitive quantitative-PCR to assess the impact of primaquine on asymptomatic relapse of Plasmodium vivax infections: a randomized, controlled trial in Lao PDR.

Authors:  Koukeo Phommasone; Frank van Leth; Mallika Imwong; Gisela Henriques; Tiengkham Pongvongsa; Bipin Adhikari; Thomas J Peto; Cholrawee Promnarate; Mehul Dhorda; Pasathorn Sirithiranont; Mavuto Mukaka; Pimnara Peerawaranun; Nicholas P J Day; Frank Cobelens; Arjen M Dondorp; Paul N Newton; Nicholas J White; Lorenz von Seidlein; Mayfong Mayxay
Journal:  Malar J       Date:  2020-01-03       Impact factor: 2.979

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.